From: Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes
Covariates | All | T2D | Non-T2D | ||||||
---|---|---|---|---|---|---|---|---|---|
OR | (95 % CI) | p-value | OR | (95 % CI) | p-value | OR | (95 % CI) | p-value | |
Framingham (age, gender, total cholesterol, HDL, SBP, smoking) | 1.37 | (1.22–1.55) | 9.5E-08 | 1.55 | (1.34–1.80) | 7.7E-09 | 1.45 | (1.14–1.85) | 3.0E-03 |
Framingham + eGFR | 1.29 | (1.14–1.45) | 5.0E-05 | 1.42 | (1.21–1.66) | 1.2E-05 | 1.43 | (1.12–1.83) | 4.0E-03 |
Framingham + RAAS inhibitors | 1.20 | (1.06–1.36) | 5.0E-03 | 1.41 | (1.21–1.65) | 1.3E-05 | 1.10 | (0.84–1.44) | ns |